加载中
NASDAQHealthcareBiotechnology
最新数据
US$31.85
−US$0.16 · -0.50%
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
前收盘价
US$31.85
−US$0.16 · -0.50%
盘中时间采用ET。市场数据可能有所延迟。
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
日内区间
当前US$31.85
52周区间
当前US$31.85
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
40
偏贵
情绪
52
多空交织
风险
43
风险偏高
动量
81
强势上行
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
日内区间
当前US$31.85
52周区间
当前US$31.85
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 |
|---|---|---|---|
| 销货成本 | 1.4亿 USD | 1.52亿 USD | — |
| 毛利 | −1.4亿 USD | −1.52亿 USD | — |
| 研究与开发 | 1.4亿 USD | 1.52亿 USD | 9759.4万 USD |
| 销售、一般及管理费用 | 3939.2万 USD | 2875.6万 USD | 2086.7万 USD |
| 营业费用 | 3939.2万 USD | 2875.6万 USD | 1.18亿 USD |
| 利息收入 | 1294.2万 USD | 1738.2万 USD | 1231.3万 USD |
| 折旧和摊销 | 242.3万 USD | 239.7万 USD | 237.6万 USD |
| 营业利润 | −1.79亿 USD | −1.81亿 USD | −1.18亿 USD |
| 净利润 | −1.66亿 USD | −1.64亿 USD | −1.06亿 USD |
公司数据更新于 2026年10月11日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$66.50
上涨空间 108.79%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI4650.39万0.00%2.3万亿 USD0.03%US$381.94+0.63%
State Street SPDR S&P Biotech ETFXBI2835.97万0.29%98.74亿 USD0.35%US$153.77+3.00%
iShares Russell 2000 ETFIWM2815.37万0.04%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF1307.26万0.01%954亿 USD0.05%US$235+0.80%
iShares Russell 2000 Growth ETFIWO690.61万0.05%139.17亿 USD0.24%US$356.78+0.94%
Vanguard Russell 2000 ETFVTWO560.93万0.03%180亿 USD0.06%US$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA518.65万0.02%218.24亿 USD0.03%US$32.79+0.40%
iShares Micro-Cap ETFIWC338.79万0.26%13.17亿 USD0.60%US$183+0.11%Vanguard Morningstar Total Stock Market ETFVTIState Street SPDR S&P Biotech ETFXBIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAiShares Micro-Cap ETFIWCAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
